Adrian Schreyer

Adrian Schreyer is a seasoned technology leader with extensive experience in artificial intelligence and drug discovery. Currently serving as the Chief Technology Officer at Xyme, Adrian previously held the same title at Anagenex and has significantly contributed to Exscientia as the VP of AI Technology, where responsibilities included building a robust team and defining a technological vision for AI-driven drug discovery. Earlier roles at Exscientia included Chief Technology Officer and Head of Molecular Informatics, emphasizing innovation in molecular design. Adrian’s academic foundation includes a PhD in Structural Bioinformatics and Drug Discovery from the University of Cambridge, complemented by a Master’s in Bioinformatics and a Bachelor’s in Applied Biology.